, typically take four to six weeks to reach full effect, and are often taken indefinitely. When the first drug specifically created to treat postpartum depression, brexanolone, was approved in 2019, it marked a breakthrough in the treatment of the condition. However, because brexanolone can only be administered via an intravenous drip, requiring a costly two-day stay in a healthcare facility, it has not been widely used.
Brexanolone and zuranolone were both developed by Biogen and Sage Pharmaceuticals and work in much the same way. Both medications modulate levels of allopregnanolone, a neuro-active steroid that is made in the body from theNow that zuranolone has been approved by the FDA, the U.S. Drug Enforcement Administration must complete a review over the next 90 days, during which it will assign a schedule to the medication, which is a controlled substance.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: Reuters - 🏆 2. / 97 Read more »